Israel - Inggeris - Ministry of Health

kamada ltd - cytomegalovirus antibody 50 iu/ml; human plasma protein 100 mg/ml - solution for injection - cytomegalovirus immunoglobulin - prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.

Israel - Inggeris - Ministry of Health

kamada ltd - bupivacaine as hydrochloride anhydrous 5 mg / 1 ml - solution for injection - bupivacaine - long acting local anaesthetic.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

kamada ltd. - human rho(d) immune globulin (unii: 48w7181flp) (human rho(d) immune globulin - unii:48w7181flp) - winrho® sdf is a rho (d) immune globulin intravenous (human) (anti-d) product that is indicated for the treatment of itp in rho (d)-positive patients and for the suppression of rh isoimmunization in non-sensitized rho (d)-negative patients. winrho® sdf is indicated for use in clinical situations requiring an increase in platelet count to prevent excessive hemorrhage in the treatment of non-splenectomized, rho (d)-positive - children with chronic or acute itp - adults with chronic itp - children and adults with itp secondary to hiv infection the safety and efficacy of winrho® sdf have not been evaluated in clinical trials for patients with non-itp causes of thrombocytopenia or in previously splenectomized patients or in patients who are rho (d)-negative. pregnancy and other obstetric conditions winrho® sdf is indicated for the suppression of rh isoimmunization in non-sensitized, rho (d)-negative (d-negative) women with a rh-incompatible pregnancy, including: - routine antepartum and postpartum rh prophylax

Singapura - Inggeris - HSA (Health Sciences Authority)

drug houses of australia private limited - rho(d) immune globulin (human) - injection - 150 mcg/ml

Israel - Inggeris - Ministry of Health

pharmalogic ltd - heparin sodium - solution for injection / infusion - heparin sodium 5000 iu/ml - heparin - heparin - • prevention of thromboembolic disorders• as part of the treatment of venous or arterial thromboembolic disorders (including the early treatment of heart attacks as well as unstable angina pectoris)• for anticoagulation during treatment or operation with an extracorporeal circulation (e.g. heart/lung machine, hemodialysis)

Kanada - Inggeris - Health Canada

searchlight pharma inc - oxtriphylline - solution - 100mg - oxtriphylline 100mg - respiratory smooth muscle relaxants

Kanada - Inggeris - Health Canada

searchlight pharma inc - oxtriphylline; guaifenesin - solution - 100mg; 50mg - oxtriphylline 100mg; guaifenesin 50mg - expectorants

Kanada - Inggeris - Health Canada

erfa canada 2012 inc - oxtriphylline - tablet (extended-release) - 600mg - oxtriphylline 600mg - respiratory smooth muscle relaxants

Kanada - Inggeris - Health Canada

erfa canada 2012 inc - oxtriphylline - tablet (extended-release) - 400mg - oxtriphylline 400mg - respiratory smooth muscle relaxants

Kanada - Inggeris - Health Canada

takeda canada inc - pioglitazone (pioglitazone hydrochloride) - tablet - 15mg - pioglitazone (pioglitazone hydrochloride) 15mg - thiazolidinediones